ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 28.06 USD 3.31% Market Closed
Market Cap: 4.7B USD

Wall Street
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 29.96 USD with a low forecast of 17.17 USD and a high forecast of 38.85 USD.

Lowest
Price Target
17.17 USD
39% Downside
Average
Price Target
29.96 USD
7% Upside
Highest
Price Target
38.85 USD
38% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
52% Upside
4593
Healios KK
126% Upside
688177
Bio-Thera Solutions Ltd
59% Upside
NIOX
Niox Group PLC
26% Upside
4BB
4Basebio PLC
182% Upside
GNFT
Genfit SA
73% Upside
CHRS
Coherus BioSciences Inc
313% Upside
GNS
Genus PLC
15% Upside

Revenue
Forecast

Revenue Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACAD's stock price target?
Price Target
29.96 USD

According to Wall Street analysts, the average 1-year price target for ACAD is 29.96 USD with a low forecast of 17.17 USD and a high forecast of 38.85 USD.

Back to Top